0 followers
Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populations.
Industries
Headquarters
Employees
Links
Andrew Parker
View all
9 members
6 members
3 members
2 members
WuXi Biologics
5 followers
Coave Therapeutics
2 followers
GENFIT
TreeFrog Therapeutics
1 follower
Vertex Pharmaceuticals
33 followers
Explore more companies